The FDA’s On­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee vot­ed 8-0 against a new in­di­ca­tion for Pfiz­er’s Talzen­na in com­bi­na­tion with Xtan­di for first-line treat­ment of adults with … Get free ...

FDA requests Moderna, Pfizer/BioNTech add safety warnings about myocarditis risk to COVID-19 vaccines, with specific rates ...

The FDA said it is making 'enhancements' designed to help states develop programs for importing cheaper drugs from Canada.

Eikon Therapeutics is laying off staff for the second time in 19 months, responding to 'changes in external circumstances' ...

The FDA's Oncologic Drugs Advisory Committee on Wednesday voted 5 to 4 against UroGen’s mitomycin as an option for low-grade ...

Mod­er­na pulls BLA for its Covid-flu shot: The com­pa­ny sug­gest­ed on its most re­cent … Get free access to a limited ...

Duncan Reece shares why his dementia care startup Veronica Health closed before seeing patients, citing fundraising challenges and investor skepticism of value-based care.

Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...

Genentech signs $105M upfront deal with Orionis Biosciences to develop molecular glue cancer drugs, with potential milestones ...

Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...

Juvenescence is out with a $76 million Series B-1, its first equity funding since before the Covid-19 pandemic.